智通财经APP讯，康华医疗(03689)发布截至2024年12月31日止年度业绩，该集团取得收益20.56亿元，同比增加0.68%;公司拥有人应占溢利1533.7万元，同比减少87.33%;每股盈利4.6分。
于报告期间，本集团取得综合溢利1050万元，而去年为溢利9100万元，同比下降88.5%。报告期间下降主要由于本集团自有医院的收入普遍下降;自2024年1月新收购的血液透析服务业务虽然为本集团带来额外收入，但仍处于亏损状态，为本集团的整体业绩增加压力;康心医院继续经营亏损;及与投资基金权益有关的公平值亏损940万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.